Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany

AIM: This study aimed to compare 6-month adherence to therapy with exenatide once weekly (Bydureon(®)) vs liraglutide once daily (Victoza(®)) in patients with type 2 diabetes under primary care in Germany. METHODS: A nationwide longitudinal prescription database (LRx), (between January 2011 and Sept...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Qing, Ouwens, Mario JNM, Grandy, Susan, Johnsson, Kristina, Kostev, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934555/
https://www.ncbi.nlm.nih.gov/pubmed/27418849
http://dx.doi.org/10.2147/DMSO.S99732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934555/
https://www.ncbi.nlm.nih.gov/pubmed/27418849
http://dx.doi.org/10.2147/DMSO.S99732

Ejemplares similares